A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lin Shen
Peking University Cancer Hospital & Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - Beijing Gobroad Hospital
Beijing, Beijing Municipality, China
Not, yet, recruiting - the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Not, yet, recruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Not, yet, recruiting - the Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Not, yet, recruiting - Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
Not, yet, recruiting - Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Apr 2026
- Primary completion
- 30 May 2028
- Completion
- 30 May 2028
- Last update posted
- 13 May 2026
- Registered enrollment
- 110
- Registry id
- NCT07390383
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.